期刊文献+

家族史在致心律失常性右心室心肌病危险分层中的地位

The status of family history for the risk stratification in arrhythmogenic right ventricular cardiomyopathy
原文传递
导出
摘要 目的探讨家族史在致心律失常性右心室心肌病(ARVC)危险分层中的地位。方法根据1994年ARVC诊断标准,纳入34例ARVC先证者,男性26例,女性8例,平均年龄(38±15)岁。对其家族成员行临床筛查,项目包括:(1)心电图V1~V3导联QRS≥110ms、V1~V3导联S波升支≥55ms、Epsilon波、T波倒置(V1~V3导联倒置)、(V1+V2+V3)/(V4+V5+V6)QRS≥1.2、V1~V3导联与V6导联QRS差值≥25ms,QRS离散度/〉40ms,QT离散度/〉65ms;(2)动态心电图记录室性早搏≥2000个/24h或室性心动过速(VT);(3)超声心动图记录双心房、双心室及右心室流出道、流人道内径大小。比较ARVC家族史和上述各项临床参数的关系。分类变量用Fisher检验,连续变量使用t检验。P≤0.05为差异有统计学意义。结果34例ARVC先证者中55个家族成员接受评估,男性28例(6例诊断ARVC)、女性27例(3例诊断ARVC),平均年龄(35±16)岁。8例先证者有家庭成员受累,其中5例有芹束支阻滞形室性心动过速(LBBB—VT,63%);26例先证者家庭成员无受累,其中20例有LBBB—VT(77%),P=0.649。家族史和室性心动过速的发生差异无统计学意义。结论家族史并不能反映ARVC的危险程度。 Objective To systematically investigate effect of family history on risk stratification in arrhythmogenic right ventrieular cardiomyopathy(ARVC) probands. Methods The study included 34 probands [ 26 men and 8 women ; mean age, (38 ± 15) years' with ARVC meeting the criteria in 1994. Their family members received clinical evaluation. The items include: (1)The value of different electrocardiogram criteria( QRS duration in V1 - V3 leads ≥ 110 ms,S-wave upstroke duration in V1 - V3 leads 〉155 ms,Epsilon potentials and T-wave inversions in the right precordial leads, (V1 + V2 + V3 )/( V4 + V5 + V6 )≥1.2 ,QRS duration in leads V1 through V3 that exceeds the QRS duration in lead V6 by t〉25 ms,QRS dispersion≥40 ms,QT dispersions〉 65 ms. (2)Ventricular tachycardia and premature ventricular contraction ( ≥ 2000 beats/24 h)during 24 h-Holter monitor. (3)The size of the atrium and ventricle from echocardiography. It is used for Fisher' s test and Student' s test to comparise the correlation among family history and these clinical parameters. A probability value of ≤0. 05 is considered significant. Results Fifty-five families members of 34 probands were evaluated,28 men(6 were ARVC)and 27 women (3 were ARVC) ;mean age (35 ± 16 )years. Five had left bundle branch block shape VT (LBBB-VT) ( 63 % ) in 8 probands who had family history; 20 had LBBB-VT ( 77 % ) in 26 probands who had not family history ; P = 0. 649. The family history was not significantly different among the ARVC probands with clinical parameters including ventricular tachycardia. Conclusion valuable parameter for the risk stratification of ARVC probands from the study.
出处 《中华心律失常学杂志》 2008年第6期421-424,共4页 Chinese Journal of Cardiac Arrhythmias
基金 广东省医学自然科学基金(A2008054)
关键词 致心律失常性有心室心肌病 家族史 室性心动过速 危险分层 Arrhythmogenic right ventricular cardiomyopathy Family history Ventricular tachycardia Risk stratification
  • 相关文献

参考文献12

  • 1Fontaine G, Fontaliran F, Hebert JL, et al. Arrhythmogenic right ventricular dysplasia. Annu Rev Mcd, 1999,50 : 17-35.
  • 2Corrado D, Basso C, Rizzoli G,et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol,2003,42:1959-1963.
  • 3Thiene G, Nava A, Corradn D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Eng J Med, 1998,318: 119-133.
  • 4Corrado D, Basso C,Thiene G, et al. Spectrum of clinicopa/hologic manifestalions of arrhythmogenic right ventricular cardiomyopathy/ dysplasia : a multicenter study. J Am Coll Cardiol, 1997,30 : 1512- 1520.
  • 5Schiφnning JD, Frederiksen P, Kristensen IB. Anhythmogenic right ventricular dysplasia as a cause of sudden death. A.rn J Forensie Med Pathol, 1997,18:345-348.
  • 6浦介麟,王洪涛,刘同库,马克娟,李宁,姚焰,楚建民,方丕华,马坚,华伟,张澍,王方正.31例致心律失常性右室心肌病的临床研究[J].中华心血管病杂志,2007,35(1):24-27. 被引量:14
  • 7Hodgkinson KA, Parfrey PS, Basselt AS, et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal dominant arrhythmogenic right ventricular cardiomyopathy ( ARVD5 ). J Am Coll Cardiol,2005 ,45 :400-408.
  • 8McKenna WJ,Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasi/cardiomyopathy: Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J,1994,71:215-218.
  • 9Hamid MS, Norman M, Quraishi A, et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol,2002,40 : 1445-1450.
  • 10Ananthasubramaniam K, Khaja F. Arrhythmogenic right ventricular dysplasia/cardiomyopathy review tor the clinician. Prog Cardiovasc Dis, 1998,41:237-246.

二级参考文献14

  • 1李宁,浦介麟.钙离子通道基因异常与室性心律失常[J].中国心脏起搏与心电生理杂志,2006,20(1):8-12. 被引量:8
  • 2Corrado D,Basso C,Thiene G.Arrhythmogenic right ventricular cardiomyopathy:diagnosis,prognosis,and treatment.Heart,2000,83(5):588-595.
  • 3McKenna WJ,Thiene G,Nava A,et al.Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy.Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.Br Heart J,1994,71(3):215-218.
  • 4Richardson P,McKeena W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93(5):841-842.
  • 5Thiene G,Basso C.Arrhythmogenic right ventricular cardiomyopathy:an update.Cardiovasc Pathol,2001,10(3):109-117.
  • 6Philippine K,Marianne B,Jeroen B,et al.Arrhythmogenic right ventricular dysplasia/cardiomyopathy:screening,diagnosis,and treatment.Heart Rhythm,2006,3(2):225-234.
  • 7McKoy G,Protonotarios N,Crosby A,et al.Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease).Lancet,2000,355(9221):2119-2124.
  • 8Maron BJ,Chaitman BR,Ackerman MJ,et al.Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.Circulation,2004,109(22):2807-2816.
  • 9Wichter T,Borggrefe M,Haverkamp W,et al.Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease.Results in patients with inducible and noninducible ventricular tachycardia.Circulation,1992,86(1):29-37.
  • 10Fontaine G,Tonet J,Gallais Y,et al.Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia:a 16-year experience.Curr Cardiol Rep,2000,2(6):498-506.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部